SCHEMBL6849264

SCHEMBL6849264

CS(=O)(=O)c1csc2cnc(C(=O)NC3CC4CCN3C4)cc12

nearest known ligand 0.42

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.42
HTR3A P46098 1/20 0.34
THRB P10828 1/20 0.32
SMYD3 Q9H7B4 2/20 0.31
CHRM4 P08173 2/20 0.30
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL842781 0.87 CHRNA7 (0.59) CHRNA7HTR3ASMYD3CHRM4
SCHEMBL842782 0.87 CHRNA7 (0.59) CHRNA7HTR3ASMYD3CHRM4
SCHEMBL6844468 0.86 CHRNA7 (0.45) CHRNA7HTR3A
SCHEMBL6850918 0.85 CHRNA7 (0.43) CHRNA7HTR3ASMYD3CHRM4
SCHEMBL6849590 0.85 CHRNA7 (0.43) CHRNA7HTR3ACHRM4
SCHEMBL6850910 0.85 CHRNA7 (0.44) CHRNA7HTR3A
SCHEMBL6848456 0.85 CHRNA7 (0.44) CHRNA7HTR3ACHRM4
SCHEMBL6844533 0.84 CHRNA7 (0.44) CHRNA7HTR3ASMYD3CHRM4
SCHEMBL6845229 0.83 CHRNA7 (0.41) CHRNA7HTR3A
SCHEMBL6848604 0.83 CHRNA7 (0.41) CHRNA7HTR3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP claimed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO claimed
EP-1432707-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2004-06-30 EP disclosed
WO-2003029252-A1 AZABICYCLIC-SUBSTITUTED FUSED-HETEROARYL COMPOUNDS FOR THE TREATMENT OF DISEASE PHARMACIA & UPJOHN COMPANY (US) 2003-04-10 WO disclosed